Indian J Gastroenterol 45 , 353356 (2026)
A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)
Documentation that would support 43274 would include: Multiple balloons were used, or There were multiple inflations in the same session
Who May Be Candidates and How to Proceed Safely with Your Provider Patients with long-standing remission, no stricture history, normal pancreatitis screening, and strong clinical indication for weight loss may be candidates for GLP-1 trial with heightened monitoring
Data 6 months prior to the index date (baseline period) and 6 months postindex date (followup period) were examined for a total study period from 15 December 2020 to 30 September 2022 (Figure 1)
Therefore, the real question is not just whether the insurer covers semaglutide, but whether your specific plan does